PPT-To PEG or not to PEG?

Author : marina-yarberry | Published Date : 2017-05-27

Karen Roberts Nutrition CNS RSCH Karen Matthews Nutrition CNS RSCHMARS team Introduction Case study PEG RIG NGT Making a decision Discharging Conclusion 49 year

Presentation Embed Code

Download Presentation

Download Presentation The PPT/PDF document "To PEG or not to PEG?" is the property of its rightful owner. Permission is granted to download and print the materials on this website for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.

To PEG or not to PEG?: Transcript

Karen Roberts Nutrition CNS RSCH Karen Matthews Nutrition CNS RSCHMARS team Introduction Case study PEG RIG NGT Making a decision Discharging Conclusion 49 year old male unknown primary with TxN3 . Creative PEGWorks supplies a unique collection of biopolymers, including polyethylene glycol products, PEG derivatives, PEGylation reagents, functional polysaccharide derivatives, PEGylated biodegradable polymers, and fluorescent and biotinylated polymers. ATTAIN. SMV + TVR placebo. + PEG-IFN + RBV. TVR + SMV placebo + PEG-IFN + RBV. Randomisation*. 1 : 1. Double-blind. ≥ 18 years. HCV genotype 1. HCV RNA ≥ 10,000 IU. /ml. Null or partial responders to . UNIT 17. Recursion: Towers of Hanoi. Unit 17. : . Recursion: Towers of Hanoi. CS1010 (AY2014/5 Semester 1). Unit17 . - . 2. © NUS. Objectives:. Understand . that many problems are more naturally solved with recursion, which can provide . To learn about recursive data structures and recursive methods for a . LinkedList. . class. To understand how to use recursion to solve the Towers of Hanoi problem. To understand how to use recursion to process two-dimensional images. 1. PEG Nanoparticles: . Production . and Drug Delivery. Structure and Function. Principles of the . NanoKit. :. A Laboratory Educational Tool . Syed K. Hasan M.D. . Ph.D. CEO/President. . Arthur . A New Approach to Optimization. Ross Tate. , Mike . Stepp. , Zach . Tatlock. , . Sorin. Lerner. University of California, San Diego. Traditional Optimization. Phase. Ordering. Problem. Local. Profitability. Hepatol. 2016; 64:19-28. MALACHITE. TVR + PEG-IFN + RBV. Randomisation. Open-label. 18-65 years. HCV genotype 1. HCV RNA > 10,000 IU/ml. Naïve (MALACHITE-I). Failure to . prior PEG-IFN + RBV. (MALACHITE-II). RBV . versus. . PEG alfa-. 2a . versus. INF + RBV . APRICOT STUDY. Phase 3. Treatment. . Naïve, Chronic HCV and HIV. Torriani. FJ, . et. al. N . Engl. J Med. . 2004;351:438-50. . PEG . + . RBV . Sarah Durham and Anne Marie . Wadlington. Rectangle Looms. 1 double rectangle loom: $9.99. Hobby Lobby . Rectangle loom kit: $24.99. Hobby Lobby . http://www.pinterest.com/search/pins/?q=loom%20knitting. Hepatol. 2016; 64:19-28. MALACHITE. TVR + PEG-IFN + RBV. Randomisation. Open-label. 18-65 years. HCV genotype 1. HCV RNA > 10,000 IU/ml. Naïve (MALACHITE-I). Failure to . prior PEG-IFN + RBV. (MALACHITE-II). SMV 24W + PEG-IFN + RBV 24-48W **. Randomisation *. 1:1. Open-label. 20-70 years, Japanese. Chronic HCV infection. Genotype 1. HCV RNA ≥ 100 000 IU. /ml. IFN-based pre-treated, . non-responders. No prior DAA therapy. W24. DCV + PR. Placebo + PR. Yes. Dore GJ. Gastroenterology 2015;148:355-66 . COMMAND GT2/3. COMMAND GT2/3 Study: . daclatasvir. + PEG-IFN . + RBV for genotype 2 or 3. DCV + PEG-IFN + RBV. N = 50. No. . PEG alfa-. 2a . versus. INF RBV . APRICOT STUDY. Phase 3. Treatment. . Naïve, Chronic HCV and HIV. Torriani. FJ, . et. al. N . Engl. J Med. . 2004;351:438-50. . PEG . . RBV . versus. . PEG . April 24, 2013. What is a Hydrogel?. Hydrophilic polymer material . that can absorb large amounts . w. ithout . dissolving. . . A . network. composed of physical or chemical . crosslinkers. that are prepared from monomers, pre-polymers, or already hydrophilic polymers. .

Download Document

Here is the link to download the presentation.
"To PEG or not to PEG?"The content belongs to its owner. You may download and print it for personal use, without modification, and keep all copyright notices. By downloading, you agree to these terms.